|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A01N 43/90 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2529622 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12166302.5 |
| Date of filing the European patent application | 2006-12-28 | |
| (97) | Date of publication of the European application | 2012-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-17 |
| (46) | Date of publication of the claims translation | 2018-05-10 |
| (30) | Number | Date | Country code |
| 826720 P | 2006-09-22 | US | |
| 828590 P | 2006-10-06 | US |
| (72) |
Honigberg, Lee, US
Verner, Erik, US
Pan, Zhengying, US
|
| (73) |
Pharmacyclics LLC,
995 East Arques Avenue, Sunnyvale, CA 94085,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Brutono tirozinkinazės inhibitoriai |
| Inhibitors of bruton`s tyrosine kinase |
| Payment date | Validity (years) | Amount | |
| 2018-12-11 | 13 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2019-02-17 |